Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.
The tech section covers stories about technology making life better, not just more profitable. Open-source tools reaching new audiences, accessibility breakthroughs, AI applications in healthcare and education, infrastructure improvements that quietly make cities work better. Product launches and funding rounds are excluded unless they deliver tangible public benefit.
A Stanford team used geospatial data and detection algorithms to achieve a tenfold increase in rescues from modern slave…
Aeron Tynes Hammack, a physicist by training and currently interim facility director of the Nanofabrication Facility at …
An international group of scientists led by Josep M. Serra-Diaz, researcher at the Botanical Institute of Barcelona (IBB…
Researchers at the Institute of Industrial Science, the University of Tokyo (UTokyo-IIS), have developed a real-time dat…